AZN - Phase 3 data for AstraZeneca's Fasenra published in NEJM
2024-02-23 15:25:33 ET
More on AstraZeneca
- AstraZeneca PLC (AZN) Q4 2023 Earnings Call Transcript
- AstraZeneca FY23 Earnings Review: It's OK To Buy Dip On Q4 Bottom Line Miss
- AstraZeneca PLC 2023 Q4 - Results - Earnings Call Presentation
- Sodexo, AstraZeneca extend global partnership for further five years
- Daiichi Sankyo-AstraZeneca gets BLA approved for lung cancer therapy in the U.S.